2BB score and signals
Atara Biotherapeutics, Inc.’s current 2BB score is 21 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 14 | Very Weak |
| Quality | 40 | Normal |
| Risk | 63 | High |
Company facts
| Headquarters | Thousand Oaks, California, United States |
| Founded | 2012 |
| Employees | 13 |
| 52-week range | $3.92 – $19.14 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-10 | — | -0.1465 | — | $510,000.00 |
| 2026-08-10 | — | -0.3213 | — | $374,003.00 |
| 2026-05-12 | -0.29 | -0.4131 | $516,000.00 | $2.91M |
| 2026-03-16 | -0.25 | -0.1748 | $1.59M | $2.52M |
Related companies